Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stifel Nicolaus Sticks to Its Buy Rating for ATS Corporation (ATS)

Tipranks - Tipranks - Fri Feb 6, 4:18AM CST

Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on ATS Corporation yesterday and set a price target of C$52.00. The company’s shares closed yesterday at C$41.22.

Claim 50% Off TipRanks Premium

According to TipRanks, Keywood is an analyst with an average return of -4.1% and a 46.27% success rate. Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, DRI Healthcare, and kneat.com.

ATS Corporation has an analyst consensus of Strong Buy, with a price target consensus of C$49.17, representing a 19.29% upside. In a report released on January 29, Scotiabank also maintained a Buy rating on the stock with a C$47.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on ATS Corporation’s latest earnings release for the quarter ending September 28, the company reported a quarterly revenue of C$728.46 million and a net profit of C$33.68 million. In comparison, last year the company earned a revenue of C$612.78 million and had a GAAP net loss of C$887 thousand

Read More on TSE:ATS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).